Région
iTeos Therapeutics is a publicly-traded (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of patients with cancer by designing and developing next generation immunotherapies.
Based in Gosselies, Belgium and Watertown, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the Duve Institute (UCLouvain) in 2011.
In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO, raising over $230 million of gross proceeds. In June 2021, the Company entered into a transformative $2.145 billion co-development and co-commercialization agreement with GSK for EOS-448, the Company’s anti-TIGIT monoclonal antibody. As a well-capitalized biotech company, we are positioned to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage our innovative science to improve the lives of patients with cancer.
.
iTeos Therapeutics is now a world-class actor in the sector. To carry on its growth and reinforce its Translational Medicine (TM) department, iTeos Therapeutics is looking for a Biomarker Leader.
Within its Translational Medicine (TM) Department, iTeos is currently actively looking for a highly motivated and creative Scientist with expertise in Immuno-Oncology or Immunology research to
take on a key role developing biomarker strategies for cutting-edge Cancer Immunotherapy projects. The selected candidate will support the discovery and implementation of biomarkers for pharmacodynamic analysis and patient selection. He/she will work in close interaction with the TM Project Lead, the TM scientists and other members of the Clinical Team to evaluate scientific hypotheses, select and evaluate the related biomarkers, including their clinical applicability, with the help of state-of-the-art technologies. He/she will support the selection, development and outsourcing of clinically applicable biomarker assays. He/she will also be responsible for data analysis and interpretation including running relevant statistical tests. Finally, in close interaction with the TM Lead and the Clinical Team, he/she will contribute in building up the scientific rationale supporting the clinical strategy.
Please send your CV together with an adapted cover letter to the following address: [email protected]. Please, mention the reference BL in the mail object. Your application and related information will remain strictly confidential.
For this position in Belgium, we closely collaborate with a Recruitment & Selection company. Your application will be automatically forwarded to them. We, together with a Recruitment & Selection company will keep all your data confidential (GDPR compliant approach).